Sutro Biopharma, Inc.
STRO
$7.30
-$0.72-8.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -56.83% | -51.85% | -20.51% | -15.63% | 9.32% |
| Total Receivables | -41.07% | 15.09% | -56.67% | -76.12% | -59.97% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -2.51% | 75.64% | 147.17% | 80.77% | 14.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -55.12% | -47.77% | -18.94% | -18.56% | 6.43% |
|
|
|||||
| Total Current Assets | -55.12% | -47.77% | -18.94% | -18.56% | 6.43% |
| Net Property, Plant & Equipment | -29.82% | -24.98% | -21.66% | -19.86% | -17.95% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -89.31% | -84.40% | -85.70% | 80.90% | 93.94% |
| Total Assets | -53.60% | -46.35% | -20.32% | -17.74% | 4.66% |
|
|
|||||
| Total Accounts Payable | 13.16% | -29.21% | 8.91% | 10.96% | 12.51% |
| Total Accrued Expenses | -23.18% | 26.66% | 29.34% | 17.69% | 50.78% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 10.51% | 16.21% | 16.36% | -28.63% | -45.89% |
| Total Finance Division Other Current Liabilities | -67.43% | -84.57% | 112.79% | 85.79% | 181.36% |
| Total Other Current Liabilities | -67.43% | -84.57% | 112.79% | 85.79% | 181.36% |
| Total Current Liabilities | -45.24% | -42.88% | 67.33% | 40.69% | 78.37% |
|
|
|||||
| Total Current Liabilities | -45.24% | -42.88% | 67.33% | 40.69% | 78.37% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -45.07% | -41.12% | -36.29% | -32.31% | -28.97% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.35% | 11.42% | -1.91% | -4.48% | -13.24% |
| Total Liabilities | -12.83% | -12.59% | 13.71% | 6.70% | 6.65% |
|
|
|||||
| Common Stock & APIC | 2.22% | 2.97% | 16.94% | 17.26% | 17.46% |
| Retained Earnings | -30.34% | -31.35% | -39.70% | -40.66% | -20.99% |
| Treasury Stock & Other | -68.87% | 92.02% | 92.04% | 85.71% | 1,414.29% |
| Total Common Equity | -178.46% | -121.10% | -126.33% | -70.20% | -1.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -178.46% | -121.10% | -126.33% | -70.20% | -1.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -178.46% | -121.10% | -126.33% | -70.20% | -1.00% |
|
|
|||||